Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Qiagen stock

Learn how to easily invest in Qiagen stock.

Qiagen NV
+ $0.06 ( + 0.15%)

Qiagen NV is a diagnostics & research business based in the US. Qiagen shares (QGEN) are listed on the NYSE and all prices are listed in US Dollars. Qiagen employs 6,100 staff and has a trailing 12-month revenue of around $2.3 billion.

How to buy shares in Qiagen

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – QGEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Qiagen stock price (NYSE: QGEN)

Use our graph to track the performance of QGEN stocks over time.

Qiagen shares at a glance

Information last updated 2022-09-26.
Latest market close$41.28
52-week range$40.99 - $58.00
50-day moving average $46.93
200-day moving average $47.92
Wall St. target price$54.56
PE ratio 18.8676
Dividend yield $0 (0%)
Earnings per share (TTM) $2.19

Buy Qiagen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Qiagen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Qiagen price performance over time

Historical closes compared with the close of $41.28 from 2022-09-30

1 week (2022-09-23) -0.10%
1 month (2022-09-02) -9.01%
3 months (2022-07-01) -13.73%
6 months (2022-04-01) -16.44%
1 year (2021-10-01) -19.03%
2 years (2020-10-02) -21.10%
3 years (2019-10-02) 30.39%
5 years (2017-10-02) 29.16%

Is Qiagen stock undervalued or overvalued?

Valuing Qiagen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Qiagen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Qiagen's P/E ratio

Qiagen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Qiagen shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Qiagen's PEG ratio

Qiagen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.651. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Qiagen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Qiagen's EBITDA

Qiagen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $855.6 million.

The EBITDA is a measure of a Qiagen's overall financial performance and is widely used to measure a its profitability.

Qiagen financials

Revenue TTM $2.3 billion
Operating margin TTM 29.06%
Gross profit TTM $1.5 billion
Return on assets TTM 6.81%
Return on equity TTM 16.43%
Profit margin 22.75%
Book value $14.42
Market capitalisation $9.4 billion

TTM: trailing 12 months

Qiagen's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Qiagen.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Qiagen's total ESG risk score

Total ESG risk: 16.36

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Qiagen's overall score of 16.36 (as at 12/31/2018) is excellent – landing it in it in the 14th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Qiagen is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Qiagen's environmental score

Environmental score: 1.25/100

Qiagen's environmental score of 1.25 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Qiagen is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Qiagen's social score

Social score: 8.53/100

Qiagen's social score of 8.53 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Qiagen is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Qiagen's governance score

Governance score: 6.07/100

Qiagen's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Qiagen is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Qiagen's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Qiagen scored a 1 out of 5 for controversy – the highest score possible, reflecting that Qiagen has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Qiagen NV was last rated for ESG on: 2019-01-01.

Total ESG score 16.36
Total ESG percentile 13.68
Environmental score 1.25
Environmental score percentile 2
Social score 8.53
Social score percentile 2
Governance score 6.07
Governance score percentile 2
Level of controversy 1

Qiagen share dividends

We're not expecting Qiagen to pay a dividend over the next 12 months.

Have Qiagen's shares ever split?

Qiagen's shares were split on a 962:1000 basis on 24 January 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 962 shares. This wouldn't directly have changed the overall worth of your Qiagen shares – just the quantity. However, indirectly, the new 4% higher share price could have impacted the market appetite for Qiagen shares which in turn could have impacted Qiagen's share price.

Qiagen share price volatility

Over the last 12 months, Qiagen's shares have ranged in value from as little as $40.99 up to $58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Qiagen's is 0.33. This would suggest that Qiagen's shares are less volatile than average (for this exchange).

Qiagen overview

QIAGEN N. V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services.

Frequently asked questions

What percentage of Qiagen is owned by insiders or institutions?
Currently 0.348% of Qiagen shares are held by insiders and 71.983% by institutions.
How many people work for Qiagen?
Latest data suggests 6,100 work at Qiagen.
When does the fiscal year end for Qiagen?
Qiagen's fiscal year ends in December.
Where is Qiagen based?
Qiagen's address is: Hulsterweg 82, Venlo, Netherlands, 5912 PL
What is Qiagen's ISIN number?
Qiagen's international securities identification number is: NL0012169213
What is Qiagen's CUSIP number?
Qiagen's Committee on Uniform Securities Identification Procedures number is: N72482107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site